Rationality of routine clinical use of olokizumab in COVID-19

Routine clinical use of olokizumab in COVID-19 is not recommended. The use of olokizumab is possible in clinical trials.

Bibliographic Details
Published in:Качественная клиническая практика
Main Authors: V. M. Tsvetov, A. V. Matveev, D. A. Sychev
Format: Article
Language:Russian
Published: Izdatelstvo OKI 2020-10-01
Subjects:
коронавирус
олокизумаб
covid-19
Online Access:https://www.clinvest.ru/jour/article/view/530
Description
Summary:Routine clinical use of olokizumab in COVID-19 is not recommended. The use of olokizumab is possible in clinical trials.
ISSN:2588-0519
2618-8473

Similar Items